<DOC>
	<DOCNO>NCT02192372</DOCNO>
	<brief_summary>Prevention contrast induce nephropathy interventional cardiologic procedure deserve close interest association prolong hospitalization , increase cost increase hospital long term mortality rate . An observational prospective cohort study design determine whether metabolic syndrome predicts development contrast induce nephropathy elective percutaneous coronary intervention .</brief_summary>
	<brief_title>Metabolic Syndrome Contrast Induced Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Patients must schedule elective percutaneous coronary intervention Clinical diagnosis metabolic syndrome Patients must give informed consent Acute coronary event Acute renal failure End stage renal failure require hemodialysis Contrast allergy exposure nephrotoxic agent within 1 week percutaneous coronary intervention Exposure contrast agent within 1 week procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>creatinine</keyword>
	<keyword>glomerular filtration rate</keyword>
	<keyword>metabolic syndrome</keyword>
</DOC>